Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

2019 BioRegion of Catalonia Presentation

40 views

Published on

The BioRegion is the healthcare and life sciences ecosystem in Catalonia, meaning the group of companies, research groups and bodies, hospitals, universities, administrations, researchers and entrepreneurs, innovation and knowledge-transfer support structures working in Catalonia in this strategic sector.

With a population of more than 7.5 millions and territory comparable to that of European countries like Belgium or the Netherlands, Catalonia has the most dynamic life sciences ecosystem in Spain and one of the most active in Europe. Biocat is the body responsible for dynamizing and promoting the BioRegion of Catalonia.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

2019 BioRegion of Catalonia Presentation

  1. 1. #InformeBiocatbiocat.cat @biocat_cat @biocat_es @biocat_es informe.biocat.cat www.biocat.cat
  2. 2. #InformeBiocatbiocat.cat INNOVATION IN H E ALT H C AR E COMPANIES / INDUSTRY R E S E AR C H HEALTH & SOCIAL IMPACT 2025 INNOVATION IN THE CATALAN LIFE SCIENCES AND HEALTHCARE SECTOR 2010
  3. 3. #InformeBiocatbiocat.cat €31,087 M 7.2% +223,000 Jobs 7% 29.5% of jobs CATALAN LIFE SCIENCES & HEALTHCARE OUTLOOK €17,802 M Industry per year of GDP of Spanish expenditure on biotech R&D activities Source: Biocat Report 2017
  4. 4. #InformeBiocatbiocat.cat 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 1,060 1,032 1,017 968 934 892 851 804 750 723 683 648 609 1 New company per week +53,700 Jobs Source: Biocat (The graphic only shows active companies) EVOLUTION OF THE COMPANIES IN THE BIOREGION OF CATALONIA (2005 – 2017)
  5. 5. #InformeBiocatbiocat.cat In the first semester of 2018, 17 multinationals announced new innovation set-ups in Catalonia. CATALONIA: A GROWING INNOVATION HUB IN EUROPE
  6. 6. #InformeBiocatbiocat.cat KEY SECTOR PLAYERS AT A WALKING DISTANCE
  7. 7. #InformeBiocatbiocat.cat S W E D E N 382 333 252 248 190 140 101 0 100 200 300 400 500 SWE DEN AUS BEL CAT FIN IR CATALONIA IS CURRENTLY ONE OF THE LEADING SCIENTIFIC HUBS IN EUROPE Sources: AGAUR (2007-March 2018);Web of Science (2013-2017) CATALONIA IRELAND AUSTRIA DENMARK FINLAND BELGIUM 304 290 280 208 181 156 89 0 100 200 300 400 SWE BEL CAT AUS DEN FIN IR ERC Grants Nature + Science
  8. 8. Source: Biocat (October 2018) Stock Market Public VC Investment Co-Development or Collaboration agreements Total FINANCE RAISED IS ON UPWARD TREND, ESPECIALLY REGARDING PRIVATE INVESTMENT (investment in startups, in €M) 2011 2012 2013 2014 2015 2016 2017 2018 9.8 28.6 56.5 60.9 56.3 40.4 107.3 100.2 36.2 164.3 65.4 8.8 21.9 85.8 16.3 9.2 (October 2018) biocat.cat Investment that creates value
  9. 9. · Source: Funds and press releases / UD: undisclosed The total local private funds specialized in life sciences available in the BioRegion sums up 570 M€ biocat.cat OPEN FUNDS SPECIALIZED IN LIFE SCIENCES EARLY PROJECTS Location VC Fund Announced Raised (M€) Goal (M€) Barcelona Healthequity Healthequity I 2013 11 Barcelona Caixa Capital Risc Caixa Innvierte BioMed II 2014 46,5 Barcelona Ysios Capital Ysios BioFund II Innvierte 2014 126 Barcelona Caixa Capital Risc Caixa Innvierte Start 2016 21,5 Madrid Columbus Columbus Innvierte Life Science 2016 41 Barcelona Inkemia InKemia Fond-ICO Global 2017 8 Barcelona Inveready Inveready Innvierte Biotech III 2018 30 Barcelona Alta Life Sciences Alta Life Sciences Spain I 2016 125 Santiago Uninvest Uninvest Technology Transfer III 2018 31 Madrid Columbus Columbus II 2019 70 Barcelona Asabys Partners Sabadell Asabys Health Innovation Fund 2019 60 Barcelona Healthequity Healthequity II 2018 UD Barcelona Nina Capital Nina Capital I 2018 UD Barcelona Ysios Capital Ysios BioFund III 2018 UD Total Funds 284 286
  10. 10. #InformeBiocatbiocat.cat INTERNATIONAL INVESTORS ARE INCREASING 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 10 1 1 1 5 6 14 22 37 50 50 International investors Source: Biocat (October 2018) (x10 in just 5 years) United States Netherlands Belgium France Switzerland Austria Germany Japan Russia United Kingdom Norway Mexico Luxembourg Italy Israel Ireland Canada China
  11. 11. #InformeBiocatbiocat.cat SUCCESS STORIES IN FUNDRAISING €11-50 M Invested €1-10 M Invested 2015 2016 2017 2018 Source: Biocat (October 2018)
  12. 12. #InformeBiocat MOVING CUTTING EDGE SCIENCE TOWARDS PATIENTS Source: Biocat and clinicaltrials.gov (October 2018) 19 new therapies developed by new companies
  13. 13. #InformeBiocatbiocat.cat THE LAST 2018 10 MONTHS IN THE BIOREGION
  14. 14. #InformeBiocatbiocat.cat LIFE SCIENCES VENTURE FINANCING (€M) BY COUNTRY (2000-2017) Source: Crunchbase a n d Biocat FINLAND CATALONIA AUSTRIA DENMARK BELGIUM SWEDEN IRELAND 1,778.8 1,034.5 289.2 1,491.3 1,125.5 592.8 483.5
  15. 15. #InformeBiocatbiocat.cat VISION 2025
  16. 16. #InformeBiocatbiocat.cat YEARLY INVESTMENT IN INNOVATIVE EMERGENT LIFE SCIENCES COMPANIES INTERNATIONAL INVESTORS INVESTING IN BIOREGION STARTUPS PRODUCTS IN CLINICAL DEVELOPMENT (THERAPIES) CATALONIA: MOST INNOVATIVE LIFE SCIENCES HUB IN EUROPE 2017 2025 130 €M/year 500 €M/year 50 18 #5 +100 50 #3 Source: Biocat Report 2017 BUILDING THE FUTURE BY LEVERAGING THE BIOREGION OF CATALONIA’S POTENTIAL
  17. 17. #InformeBiocatbiocat.cat Many hubs start-up… just a few scale-up @biocat_cat @biocat_es @biocat_es informe.biocat.cat www.biocat.cat

×